CMS advises Lightrock in connection with AMBOSS's EUR 240 million financing round

Frankfurt – Lightrock has participated in Amboss SE's EUR 240 million financing round. Lightrock is a global investment platform committed to building a sustainable future. Operating across private and public markets, Lightrock is a B Corp and its funds invest in Europe, North America, Latin America, Asia and Africa.

A CMS team provided comprehensive legal advice to Lightrock on the investment. CMS has supported Lightrock in the past.

AMBOSS is a platform for doctors. It quickly provides up-to-date knowledge and thus contributes to efficient, evidence-based healthcare. Around the world, 500,000 doctors already rely on AMBOSS in their work, studies and teaching.

Press Contact
presse@cms-hs.com